Miltiadis Georgiadis

Mr. Miltiadis Georgiadis

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2025 in COVID
Verified
Journal Article
Open access
PDF file
MGMiltiadis Georgiadis
Miltiadis Georgiadis
NANuriye Akyol
Nuriye Akyol
LKLars Kamper
Lars Kamper
NNNima Nadem-Boueini
Nima Nadem-Boueini
AZAthanasios Ziakos
Athanasios Ziakos
NANadine Abanador-Kamper
Nadine Abanador-Kamper
After SARS-CoV-2 infection, a subset of patients experience persistent cardiac symptoms, yet data on long-term cardiac involvement and clinical outcomes in the post-COVID-19 condition remain limited. This study aimed to investigate myocardial abnormalities using advanced cardiovascular magnetic resonance (CMR) imaging techniques in patients with ongoing cardiac symptoms for at least three months following COVID-19 diagnosis, and to assess their clinical outcomes. Between January 2021 and March 2022, 94 post-COVID-19 patients were examined at a median of 99 days (IQR 92–110) after diagnosis and compared to 100 controls. The CMR assessment included the left ventricular ejection fraction (LVEF), myocardial T2 signal, late gadolinium enhancement (LGE), and myocardial strain parameters. Follow-up for major adverse cardiac events (MACEs) was conducted at a median of 269 days (IQR 144–352). While no significant differences in LVEF were observed, post-COVID-19 patients demonstrated significantly reduced peak radial and circumferential strain values, suggesting subclinical myocardial dysfunction. Additionally, these patients exhibited a higher event rate compared to controls (0.063 vs. 0; p = 0.029). These findings indicate that patients with cardiac symptoms following COVID-19 may exhibit subtle but measurable myocardial changes and an increased risk of adverse outcomes. The observed alterations in myocardial strain most likely reflect mild, subclinical myocardial involvement within the spectrum of post-COVID-19 effects, rather than a direct cause of persistent symptoms. Further research is warranted to determine the prognostic significance of these findings.

29 May 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
MGMiltiadis Georgiadis
Miltiadis Georgiadis
AZAthanasios Ziakos
Athanasios Ziakos
LKLars Kamper
Lars Kamper
PHPatrick Haage
Patrick Haage
MSMelchior Seyfarth
Melchior Seyfarth
NANadine Abanador-Kamper
Nadine Abanador-Kamper
Background: Takotsubo syndrome (TTS) is a condition first identified in the 1990s in the Japanese population. It is believed that 1%–2% of acute coronary syndromes are due to TTS. The pathophysiological mechanism involves acute activation of the sympathetic nervous system with a cataclysmic release of catecholamines, causing acute myocardial dysfunction. Case summary: We report a case of an 18-year-old female patient who suffered an out-of-hospital cardiac arrest due to ventricular fibrillation of unknown etiology. Emergency cardiac catheterization revealed normal coronaries and hypokinesia of the apical segments. The patient was admitted to the ICU with refractory cardiogenic shock, necessitating extracorporeal life support measures. Serial echocardiograms showed rapid deterioration of left ventricular function. The diagnosis of TTS was confirmed with an early cardiovascular magnetic resonance study. A corrected QT interval (QTc) prolongation was observed intermittently. The patient showed an excellent neurological outcome and was discharged after implantable cardioverter defibrillator implantation for ambulatory care. Genetic testing revealed a previously unpublished KCNH2 gene mutation. Mutations in this gene are known to cause long QT syndrome (LQTS). Discussion: Our case presents a secondary TTS after surviving a sudden cardiac arrest in a teenager with so far unknown LQTS2-associated ventricular fibrillation. We emphasize the importance of repeated electrocardiogram recordings and serial echocardiography in unexplained cardiogenic shock. Our case highlights the importance of an early multimodal therapeutic approach in the management of TTS to improve patient outcomes in this complex clinical entity.